Global Mononucleosis Diagnostic Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Monospot Test
  • 1.2.3 Complete Blood Count Test
  • 1.2.4 Epstein Barr Virus (EBV) Antibody Test
• 1.3 Market by Application
  • 1.3.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Laboratories
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Mononucleosis Diagnostic Market Perspective (2017-2028)
• 2.2 Mononucleosis Diagnostic Growth Trends by Region
  • 2.2.1 Mononucleosis Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Mononucleosis Diagnostic Historic Market Size by Region (2017-2022)
  • 2.2.3 Mononucleosis Diagnostic Forecasted Market Size by Region (2023-2028)
• 2.3 Mononucleosis Diagnostic Market Dynamics
  • 2.3.1 Mononucleosis Diagnostic Industry Trends
  • 2.3.2 Mononucleosis Diagnostic Market Drivers
  • 2.3.3 Mononucleosis Diagnostic Market Challenges
  • 2.3.4 Mononucleosis Diagnostic Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Mononucleosis Diagnostic Players by Revenue
  • 3.1.1 Global Top Mononucleosis Diagnostic Players by Revenue (2017-2022)
  • 3.1.2 Global Mononucleosis Diagnostic Revenue Market Share by Players (2017-2022)
• 3.2 Global Mononucleosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Mononucleosis Diagnostic Revenue
• 3.4 Global Mononucleosis Diagnostic Market Concentration Ratio
  • 3.4.1 Global Mononucleosis Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Mononucleosis Diagnostic Revenue in 2021
• 3.5 Mononucleosis Diagnostic Key Players Head office and Area Served
• 3.6 Key Players Mononucleosis Diagnostic Product Solution and Service
• 3.7 Date of Enter into Mononucleosis Diagnostic Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Mononucleosis Diagnostic Breakdown Data by Type

• 4.1 Global Mononucleosis Diagnostic Historic Market Size by Type (2017-2022)
• 4.2 Global Mononucleosis Diagnostic Forecasted Market Size by Type (2023-2028)

5 Mononucleosis Diagnostic Breakdown Data by Application

• 5.1 Global Mononucleosis Diagnostic Historic Market Size by Application (2017-2022)
• 5.2 Global Mononucleosis Diagnostic Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Mononucleosis Diagnostic Market Size (2017-2028)
• 6.2 North America Mononucleosis Diagnostic Market Size by Type
  • 6.2.1 North America Mononucleosis Diagnostic Market Size by Type (2017-2022)
  • 6.2.2 North America Mononucleosis Diagnostic Market Size by Type (2023-2028)
  • 6.2.3 North America Mononucleosis Diagnostic Market Share by Type (2017-2028)
• 6.3 North America Mononucleosis Diagnostic Market Size by Application
  • 6.3.1 North America Mononucleosis Diagnostic Market Size by Application (2017-2022)
  • 6.3.2 North America Mononucleosis Diagnostic Market Size by Application (2023-2028)
  • 6.3.3 North America Mononucleosis Diagnostic Market Share by Application (2017-2028)
• 6.4 North America Mononucleosis Diagnostic Market Size by Country
  • 6.4.1 North America Mononucleosis Diagnostic Market Size by Country (2017-2022)
  • 6.4.2 North America Mononucleosis Diagnostic Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Mononucleosis Diagnostic Market Size (2017-2028)
• 7.2 Europe Mononucleosis Diagnostic Market Size by Type
  • 7.2.1 Europe Mononucleosis Diagnostic Market Size by Type (2017-2022)
  • 7.2.2 Europe Mononucleosis Diagnostic Market Size by Type (2023-2028)
  • 7.2.3 Europe Mononucleosis Diagnostic Market Share by Type (2017-2028)
• 7.3 Europe Mononucleosis Diagnostic Market Size by Application
  • 7.3.1 Europe Mononucleosis Diagnostic Market Size by Application (2017-2022)
  • 7.3.2 Europe Mononucleosis Diagnostic Market Size by Application (2023-2028)
  • 7.3.3 Europe Mononucleosis Diagnostic Market Share by Application (2017-2028)
• 7.4 Europe Mononucleosis Diagnostic Market Size by Country
  • 7.4.1 Europe Mononucleosis Diagnostic Market Size by Country (2017-2022)
  • 7.4.2 Europe Mononucleosis Diagnostic Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Mononucleosis Diagnostic Market Size (2017-2028)
• 8.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type
  • 8.2.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Mononucleosis Diagnostic Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Application
  • 8.3.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Mononucleosis Diagnostic Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Mononucleosis Diagnostic Market Size by Region
  • 8.4.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Mononucleosis Diagnostic Market Size (2017-2028)
• 9.2 Latin America Mononucleosis Diagnostic Market Size by Type
  • 9.2.1 Latin America Mononucleosis Diagnostic Market Size by Type (2017-2022)
  • 9.2.2 Latin America Mononucleosis Diagnostic Market Size by Type (2023-2028)
  • 9.2.3 Latin America Mononucleosis Diagnostic Market Share by Type (2017-2028)
• 9.3 Latin America Mononucleosis Diagnostic Market Size by Application
  • 9.3.1 Latin America Mononucleosis Diagnostic Market Size by Application (2017-2022)
  • 9.3.2 Latin America Mononucleosis Diagnostic Market Size by Application (2023-2028)
  • 9.3.3 Latin America Mononucleosis Diagnostic Market Share by Application (2017-2028)
• 9.4 Latin America Mononucleosis Diagnostic Market Size by Country
  • 9.4.1 Latin America Mononucleosis Diagnostic Market Size by Country (2017-2022)
  • 9.4.2 Latin America Mononucleosis Diagnostic Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Mononucleosis Diagnostic Market Size (2017-2028)
• 10.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type
  • 10.2.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Mononucleosis Diagnostic Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Application
  • 10.3.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Mononucleosis Diagnostic Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Mononucleosis Diagnostic Market Size by Country
  • 10.4.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Mononucleosis Diagnostic Introduction
  • 11.1.4 Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.1.5 Abbott Laboratories Recent Developments
• 11.2 ELITechGroup
  • 11.2.1 ELITechGroup Company Details
  • 11.2.2 ELITechGroup Business Overview
  • 11.2.3 ELITechGroup Mononucleosis Diagnostic Introduction
  • 11.2.4 ELITechGroup Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.2.5 ELITechGroup Recent Developments
• 11.3 Beckman Coulter
  • 11.3.1 Beckman Coulter Company Details
  • 11.3.2 Beckman Coulter Business Overview
  • 11.3.3 Beckman Coulter Mononucleosis Diagnostic Introduction
  • 11.3.4 Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.3.5 Beckman Coulter Recent Developments
• 11.4 Bio-Rad Laboratories
  • 11.4.1 Bio-Rad Laboratories Company Details
  • 11.4.2 Bio-Rad Laboratories Business Overview
  • 11.4.3 Bio-Rad Laboratories Mononucleosis Diagnostic Introduction
  • 11.4.4 Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.4.5 Bio-Rad Laboratories Recent Developments
• 11.5 Cardinal Health
  • 11.5.1 Cardinal Health Company Details
  • 11.5.2 Cardinal Health Business Overview
  • 11.5.3 Cardinal Health Mononucleosis Diagnostic Introduction
  • 11.5.4 Cardinal Health Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.5.5 Cardinal Health Recent Developments
• 11.6 Immunostics
  • 11.6.1 Immunostics Company Details
  • 11.6.2 Immunostics Business Overview
  • 11.6.3 Immunostics Mononucleosis Diagnostic Introduction
  • 11.6.4 Immunostics Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.6.5 Immunostics Recent Developments
• 11.7 Meridian Bioscience
  • 11.7.1 Meridian Bioscience Company Details
  • 11.7.2 Meridian Bioscience Business Overview
  • 11.7.3 Meridian Bioscience Mononucleosis Diagnostic Introduction
  • 11.7.4 Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.7.5 Meridian Bioscience Recent Developments
• 11.8 Quidel Corporation
  • 11.8.1 Quidel Corporation Company Details
  • 11.8.2 Quidel Corporation Business Overview
  • 11.8.3 Quidel Corporation Mononucleosis Diagnostic Introduction
  • 11.8.4 Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.8.5 Quidel Corporation Recent Developments
• 11.9 Sekisui Diagnostics
  • 11.9.1 Sekisui Diagnostics Company Details
  • 11.9.2 Sekisui Diagnostics Business Overview
  • 11.9.3 Sekisui Diagnostics Mononucleosis Diagnostic Introduction
  • 11.9.4 Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.9.5 Sekisui Diagnostics Recent Developments
• 11.10 Thermo Fischer Scientific
  • 11.10.1 Thermo Fischer Scientific Company Details
  • 11.10.2 Thermo Fischer Scientific Business Overview
  • 11.10.3 Thermo Fischer Scientific Mononucleosis Diagnostic Introduction
  • 11.10.4 Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.10.5 Thermo Fischer Scientific Recent Developments
• 11.11 Siemens
  • 11.11.1 Siemens Company Details
  • 11.11.2 Siemens Business Overview
  • 11.11.3 Siemens Mononucleosis Diagnostic Introduction
  • 11.11.4 Siemens Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.11.5 Siemens Recent Developments
• 11.12 Biomerieux
  • 11.12.1 Biomerieux Company Details
  • 11.12.2 Biomerieux Business Overview
  • 11.12.3 Biomerieux Mononucleosis Diagnostic Introduction
  • 11.12.4 Biomerieux Revenue in Mononucleosis Diagnostic Business (2017-2022)
  • 11.12.5 Biomerieux Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Mononucleosis Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Monospot Test
• Table 3. Key Players of Complete Blood Count Test
• Table 4. Key Players of Epstein Barr Virus (EBV) Antibody Test
• Table 5. Global Mononucleosis Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 6. Global Mononucleosis Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 7. Global Mononucleosis Diagnostic Market Size by Region (2017-2022) & (US$ Million)
• Table 8. Global Mononucleosis Diagnostic Market Share by Region (2017-2022)
• Table 9. Global Mononucleosis Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 10. Global Mononucleosis Diagnostic Market Share by Region (2023-2028)
• Table 11. Mononucleosis Diagnostic Market Trends
• Table 12. Mononucleosis Diagnostic Market Drivers
• Table 13. Mononucleosis Diagnostic Market Challenges
• Table 14. Mononucleosis Diagnostic Market Restraints
• Table 15. Global Mononucleosis Diagnostic Revenue by Players (2017-2022) & (US$ Million)
• Table 16. Global Mononucleosis Diagnostic Revenue Share by Players (2017-2022)
• Table 17. Global Top Mononucleosis Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mononucleosis Diagnostic as of 2021)
• Table 18. Ranking of Global Top Mononucleosis Diagnostic Companies by Revenue (US$ Million) in 2021
• Table 19. Global 5 Largest Players Market Share by Mononucleosis Diagnostic Revenue (CR5 and HHI) & (2017-2022)
• Table 20. Key Players Headquarters and Area Served
• Table 21. Key Players Mononucleosis Diagnostic Product Solution and Service
• Table 22. Date of Enter into Mononucleosis Diagnostic Market
• Table 23. Mergers & Acquisitions, Expansion Plans
• Table 24. Global Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 25. Global Mononucleosis Diagnostic Revenue Market Share by Type (2017-2022)
• Table 26. Global Mononucleosis Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 27. Global Mononucleosis Diagnostic Revenue Market Share by Type (2023-2028)
• Table 28. Global Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 29. Global Mononucleosis Diagnostic Revenue Share by Application (2017-2022)
• Table 30. Global Mononucleosis Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 31. Global Mononucleosis Diagnostic Revenue Share by Application (2023-2028)
• Table 32. North America Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 33. North America Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 34. North America Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 35. North America Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 36. North America Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 37. North America Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 38. Europe Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 39. Europe Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 40. Europe Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 41. Europe Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 42. Europe Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 43. Europe Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 44. Asia Pacific Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 45. Asia Pacific Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 46. Asia Pacific Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 47. Asia Pacific Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 48. Asia Pacific Mononucleosis Diagnostic Market Size by Region (2017-2022) & (US$ Million)
• Table 49. Asia Pacific Mononucleosis Diagnostic Market Size by Region (2023-2028) & (US$ Million)
• Table 50. Latin America Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 51. Latin America Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 52. Latin America Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 53. Latin America Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 54. Latin America Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 55. Latin America Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 56. Middle East and Africa Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 57. Middle East and Africa Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 58. Middle East and Africa Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 59. Middle East and Africa Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 60. Middle East and Africa Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 61. Middle East and Africa Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 62. Abbott Laboratories Company Details
• Table 63. Abbott Laboratories Business Overview
• Table 64. Abbott Laboratories Mononucleosis Diagnostic Product
• Table 65. Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 66. Abbott Laboratories Recent Developments
• Table 67. ELITechGroup Company Details
• Table 68. ELITechGroup Business Overview
• Table 69. ELITechGroup Mononucleosis Diagnostic Product
• Table 70. ELITechGroup Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 71. ELITechGroup Recent Developments
• Table 72. Beckman Coulter Company Details
• Table 73. Beckman Coulter Business Overview
• Table 74. Beckman Coulter Mononucleosis Diagnostic Product
• Table 75. Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 76. Beckman Coulter Recent Developments
• Table 77. Bio-Rad Laboratories Company Details
• Table 78. Bio-Rad Laboratories Business Overview
• Table 79. Bio-Rad Laboratories Mononucleosis Diagnostic Product
• Table 80. Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 81. Bio-Rad Laboratories Recent Developments
• Table 82. Cardinal Health Company Details
• Table 83. Cardinal Health Business Overview
• Table 84. Cardinal Health Mononucleosis Diagnostic Product
• Table 85. Cardinal Health Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 86. Cardinal Health Recent Developments
• Table 87. Immunostics Company Details
• Table 88. Immunostics Business Overview
• Table 89. Immunostics Mononucleosis Diagnostic Product
• Table 90. Immunostics Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 91. Immunostics Recent Developments
• Table 92. Meridian Bioscience Company Details
• Table 93. Meridian Bioscience Business Overview
• Table 94. Meridian Bioscience Mononucleosis Diagnostic Product
• Table 95. Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 96. Meridian Bioscience Recent Developments
• Table 97. Quidel Corporation Company Details
• Table 98. Quidel Corporation Business Overview
• Table 99. Quidel Corporation Mononucleosis Diagnostic Product
• Table 100. Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 101. Quidel Corporation Recent Developments
• Table 102. Sekisui Diagnostics Company Details
• Table 103. Sekisui Diagnostics Business Overview
• Table 104. Sekisui Diagnostics Mononucleosis Diagnostic Product
• Table 105. Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 106. Sekisui Diagnostics Recent Developments
• Table 107. Thermo Fischer Scientific Company Details
• Table 108. Thermo Fischer Scientific Business Overview
• Table 109. Thermo Fischer Scientific Mononucleosis Diagnostic Product
• Table 110. Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 111. Thermo Fischer Scientific Recent Developments
• Table 112. Siemens Company Details
• Table 113. Siemens Business Overview
• Table 114. Siemens Mononucleosis Diagnostic Product
• Table 115. Siemens Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 116. Siemens Recent Developments
• Table 117. Biomerieux Company Details
• Table 118. Biomerieux Business Overview
• Table 119. Biomerieux Mononucleosis Diagnostic Product
• Table 120. Biomerieux Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
• Table 121. Biomerieux Recent Developments
• Table 122. Research Programs/Design for This Report
• Table 123. Key Data Information from Secondary Sources
• Table 124. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Mononucleosis Diagnostic Market Share by Type: 2021 VS 2028
• Figure 2. Monospot Test Features
• Figure 3. Complete Blood Count Test Features
• Figure 4. Epstein Barr Virus (EBV) Antibody Test Features
• Figure 5. Global Mononucleosis Diagnostic Market Share by Application: 2021 VS 2028
• Figure 6. Hospitals Case Studies
• Figure 7. Laboratories Case Studies
• Figure 8. Others Case Studies
• Figure 9. Mononucleosis Diagnostic Report Years Considered
• Figure 10. Global Mononucleosis Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 11. Global Mononucleosis Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Mononucleosis Diagnostic Market Share by Region: 2021 VS 2028
• Figure 13. Global Mononucleosis Diagnostic Market Share by Players in 2021
• Figure 14. Global Top Mononucleosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mononucleosis Diagnostic as of 2021)
• Figure 15. The Top 10 and 5 Players Market Share by Mononucleosis Diagnostic Revenue in 2021
• Figure 16. North America Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 17. North America Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 18. North America Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 19. North America Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
• Figure 20. United States Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Canada Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 22. Europe Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 23. Europe Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 24. Europe Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 25. Europe Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
• Figure 26. Germany Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. France Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. U.K. Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Italy Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Russia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Nordic Countries Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Asia-Pacific Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 33. Asia Pacific Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 34. Asia Pacific Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 35. Asia Pacific Mononucleosis Diagnostic Market Size Share by Region (2017-2028)
• Figure 36. China Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Japan Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. South Korea Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. Southeast Asia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. India Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Australia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 42. Latin America Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 43. Latin America Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 44. Latin America Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 45. Latin America Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
• Figure 46. Mexico Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Brazil Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 48. Middle East & Africa Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 49. Middle East and Africa Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 50. Middle East and Africa Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 51. Middle East and Africa Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
• Figure 52. Turkey Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Saudi Arabia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. UAE Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. Abbott Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 56. ELITechGroup Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 57. Beckman Coulter Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 59. Cardinal Health Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 60. Immunostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 61. Meridian Bioscience Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 62. Quidel Corporation Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 63. Sekisui Diagnostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 64. Thermo Fischer Scientific Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 65. Siemens Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 66. Biomerieux Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
• Figure 67. Bottom-up and Top-down Approaches for This Report
• Figure 68. Data Triangulation
• Figure 69. Key Executives Interviewed